TRK fused gene antibody

Synonyms:FLJ36137 antibody, Protein TFG antibody, TF6 antibody, TFG antibody, TRK fused gene antibody, TRK fused gene protein antibody, TRKT3 antibody
Catalogue No.:FNab09001Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, WB, IHC
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
TRK fused gene antibody
Catalogue No.
FNab09001
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
TRK-fused gene
Alternative Names
FLJ36137 antibody, Protein TFG antibody, TF6 antibody, TFG antibody, TRK fused gene antibody, TRK fused gene protein antibody, TRKT3 antibody
UniProt ID
Q92734
Observed MW
50-55 kDa
Application
Tested Applications
ELISA, WB, IHC
Recommended dilution
WB: 1:500-1:5000; IHC: 1:20-1:200; IF: 1:50-1:500
Validated Images
A549 cells were subjected to SDS PAGE followed by western blot with FNab09001(TFG antibody) at dilution of 1:400
Immunohistochemistry of paraffin-embedded human gliomas using FNab09001(TFG antibody) at dilution of 1:100
Background
Protein TFG(TRK-fused gene protein) plays a role in regulating phosphotyrosine-specific phosphatase-1 activity. Mutations in TFG may have important clinical relevance for current therapeutic strategies to treat metastatic melanoma. Defects in TFG are a cause of thyroid papillary carcinoma(TPC), a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Hereditary motor and sensory neuropathy with proximal dominant involvement(HMSN-P) is an autosomal-dominant neurodegenerative disorder characterized by widespread fasciculations, proximal-predominant muscle weakness, and atrophy followed by distal sensory involvement. Recent genetic investigation indicates that formation of TFG-containing cytoplasmic inclusions and concomitant mislocalization of TAR DNA-binding protein 43 kDa(TDP-43) underlie motor neuron degeneration in HMSN-P. Pathological overlap of proteinopathies involving TFG and TDP-43 highlights a new pathway leading to motor neuron degeneration.